-+ 0.00%
-+ 0.00%
-+ 0.00%
MeiraGTx Gene Therapy Stabilizes Weight in Mouse Study of Genetic Obesity
Share
Listen to the news
MeiraGTx Gene Therapy Stabilizes Weight in Mouse Study of Genetic Obesity
  • MeiraGTx will present preclinical results for its AAV-BDNF gene therapy at ObesityWeek on Nov. 16, 2026.
  • A single injection stabilized weight and normalized glucose tolerance in mice with BDNF deficiency, supporting potential treatment for rare genetic obesity.
  • Treatment also reduced aggressive behaviors without impairing social interactions. Blood tests showed a favorable safety profile.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MeiraGTx Holdings plc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611160700PRIMZONEFULLFEED9877668) on November 16, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending